Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Mem. Inst. Oswaldo Cruz ; 107(6): 713-719, set. 2012. ilus, tab
Article Dans Anglais | LILACS | ID: lil-649484

Résumé

Protein tyrosine phosphatases (PTPs) play an essential role in the regulation of cell differentiation in pathogenic trypanosomatids. In this study, we describe a PTP expressed by the non-pathogenic protozoan Trypanosoma rangeli (TrPTP2). The gene for this PTP is orthologous to the T. brucei TbPTP1 and Trypanosoma cruzi (TcPTP2) genes. Cloning and expression of the TrPTP2 and TcPTP2 proteins allowed anti-PTP2 monoclonal antibodies to be generated in BALB/c mice. When expressed by T. rangeli epimastigotes and trypomastigotes, native TrPTP2 is detected as a ~65 kDa protein associated with the parasite's flagellum. Given that the flagellum is an important structure for cell differentiation in trypanosomatids, the presence of a protein responsible for tyrosine dephosphorylation in the T. rangeli flagellum could represent an interesting mechanism of regulation in this structure.


Sujets)
Animaux , Souris , Anticorps monoclonaux/immunologie , Flagelles/enzymologie , Protein Tyrosine Phosphatases/métabolisme , Trypanosoma rangeli/enzymologie , Immunisation , Souris de lignée BALB C , Phylogenèse , Protein Tyrosine Phosphatases/génétique , Trypanosoma rangeli/génétique , Trypanosoma rangeli/immunologie
2.
Mem. Inst. Oswaldo Cruz ; 106(1): 32-37, Feb. 2011. ilus, graf, tab
Article Dans Anglais | LILACS | ID: lil-578813

Résumé

In America, there are two species of Trypanosoma that can infect humans: Trypanosoma cruzi, which is responsible for Chagas disease and Trypanosoma rangeli, which is not pathogenic. We have developed a model of vaccination in mice with T. rangeli epimastigotes that protects against T. cruzi infection. The goal of this work was to study the pattern of specific immunoglobulins in the peritoneum (the site of infection) and in the sera of mice immunized with T. rangeli before and after challenge with T. cruzi. Additionally, we studied the effects triggered by antigen-antibodies binding and the levels of key cytokines involved in the humoral response, such as IL-4, IL-5 and IL-6. The immunization triggered the production of antibodies reactive with T. cruzi in peritoneal fluid (PF) and in serum, mainly IgG1 and, to a lesser magnitude, IgG2. Only immunized mice developed specific IgG3 antibodies in their peritoneal cavities. Antibodies were able to bind to the surface of the parasites and agglutinate them. Among the cytokines studied, IL-6 was elevated in PF during early infection, with higher levels in non-immunized-infected mice. The results indicate that T. rangeli vaccination against T. cruzi infection triggers a high production of specific IgG isotypes in PF and sera before infection and modulates the levels of IL-6 in PF in the early periods of infection.


Sujets)
Animaux , Souris , Anticorps antiprotozoaires/immunologie , Antigènes de protozoaire/immunologie , Maladie de Chagas/immunologie , Immunoglobulines/immunologie , /immunologie , Vaccins antiprotozoaires/immunologie , Trypanosoma rangeli/immunologie , Anticorps antiprotozoaires/sang , Modèles animaux de maladie humaine , Test ELISA , Technique d'immunofluorescence indirecte , Tests d'hémagglutination , Interleukines/immunologie , Souris de lignée BALB C
SÉLECTION CITATIONS
Détails de la recherche